Anesthetic management of rhinoorbitocerebral mucormycosis; Focus on challenges

Basit Öğe Kaydı
dc.authoridkaraaslan, erol/0000-0002-8534-3680
dc.authorwosidkaraaslan, erol/ABI-2700-2020
dc.contributor.authorKaraaslan, E.
dc.date.accessioned2024-08-04T20:46:48Z
dc.date.available2024-08-04T20:46:48Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description.abstractMucormycosis is a progressive, opportunistic fungal infection with a high risk of mortality. Also mucormycosis may attack any organ system and may be accompanied by hemodynamic instability and difficult airway management. This study aimed to evaluate the anesthetic management of patients undergoing surgical resection for rhino-orbito-cerebral mucormycosis (ROC). The study evaluated 12 patients that underwent surgical resection for ROC mucormycosis under general anesthesia. Demographic characteristics, hemodynamic parameters, invasive monitoring methods, surgical procedures, hospital records, and mortality rates were reviewed for each patient. The patients had a median age of 58 (range, 5-86) years. Two patients had an American Society of Anesthesiologists (ASA) score of II while the remaining 10 patients had a score of III. Eleven (91.7%) patients had a diagnosis of rhino-orbital mucormycosis and 1 (8.3%) patient was diagnosed with ROC mucormycosis. Most common comorbidity was DM (n=8), followed by hematological malignancy (n=4), solid organ malignancy (n=3), and kidney transplantation (n=2). Invasive arterial monitoring was performed in 7 and central venous cannulation was performed in 5 patients. Six patients were transferred to the intensive care unit (ICU) and the mortality rate was 25% with an average mortality time was 7 days in 3 cases. In cases of ROC mucormycosis, necessary precautions should be taken for the difficult airway caused by fungal debris in the oropharyngeal region and supraglottic edema. Postoperative ICU is important due to comorbidities and fungal infection with high mortality. (C) 2019 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.doi10.1016/j.mycmed.2019.07.001
dc.identifier.endpage222en_US
dc.identifier.issn1156-5233
dc.identifier.issn1773-0449
dc.identifier.issue3en_US
dc.identifier.pmid31399350en_US
dc.identifier.scopus2-s2.0-85072792047en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage219en_US
dc.identifier.urihttps://doi.org/10.1016/j.mycmed.2019.07.001
dc.identifier.urihttps://hdl.handle.net/11616/98968
dc.identifier.volume29en_US
dc.identifier.wosWOS:000494888900003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMasson Editeuren_US
dc.relation.ispartofJournal De Mycologie Medicaleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnesthetic managementen_US
dc.subjectMortalityen_US
dc.subjectRhino-orbito-cerebral mucormycosisen_US
dc.titleAnesthetic management of rhinoorbitocerebral mucormycosis; Focus on challengesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu